hypericin has been researched along with Carcinoma in 8 studies
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin is a bright red fluorescent compound that can be used in urological medicine as a photodiagnostic to detect non-muscle-invasive bladder cancer lesions." | 7.77 | Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids. ( de Witte, PA; Lerut, E; Roelants, M; Van Cleynenbreugel, B; Van Poppel, H, 2011) |
| "Photodynamic diagnosis (PDD) using hypericin (HY), a natural photosensitizer, detects bladder cancer significantly better than white light endoscopy." | 7.74 | Effects of N-methyl pyrrolidone on the uptake of hypericin in human bladder carcinoma and co-staining with DAPI investigated by confocal microscopy. ( Fu, CY; Kho, KW; Olivo, M; Saw, CL; Sia Heng, PW; Soo, KC; Wohland, T, 2007) |
| "Photosensitization of HEC1-B cells with a low concentration of hypericin and doses of light below 10 J/cm(2) caused cell death (apoptosis occurred mainly at doses between 2 and 5 J/cm(2), whereas necrosis prevailed above 6 J/cm(2))." | 7.71 | Molecular aspects of photodynamic therapy: low energy pre-sensitization of hypericin-loaded human endometrial carcinoma cells enhances photo-tolerance, alters gene expression and affects the cell cycle. ( Coppola, E; Palumbo, G; Quarto, M; Varriale, L; Veneziani, BM, 2002) |
| "In order to explore the combined effects of gene therapy and hypericin (Hy) on tumor cells, hypoxia-inducible factor 1 alpha (HIF-1α) small interfering ribonucleic acid (siRNA) was transfected into the hypoxic human nasopharyngeal carcinoma (CNE2) cells using Hy-encapsulated nanocomplexes (Hy-HPP NPs) as a carrier which would achieve dual targeting to the tumor necrosis area." | 3.83 | Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles. ( Li, Y; Ouahab, A; Shen, Y; Wang, B; Zhang, J, 2016) |
| " Therefore, we preloaded microplates with hypericin, Foscan, PVP-hypericin, or aluminum (III) phthalocyanine tetrasulfonate chloride (AlPCS4) for 24 hours and measured the PS distribution after addition of A431 human carcinoma cells: following another 24 hours up to 68% of hypericin were detected in the cell fraction." | 3.79 | Photosensitizer adhered to cell culture microplates induces phototoxicity in carcinoma cells. ( Kiesslich, T; Krammer, B; Plaetzer, K; Ziegler, V, 2013) |
| "Hypericin is a bright red fluorescent compound that can be used in urological medicine as a photodiagnostic to detect non-muscle-invasive bladder cancer lesions." | 3.77 | Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids. ( de Witte, PA; Lerut, E; Roelants, M; Van Cleynenbreugel, B; Van Poppel, H, 2011) |
| "Photodynamic diagnosis (PDD) using hypericin (HY), a natural photosensitizer, detects bladder cancer significantly better than white light endoscopy." | 3.74 | Effects of N-methyl pyrrolidone on the uptake of hypericin in human bladder carcinoma and co-staining with DAPI investigated by confocal microscopy. ( Fu, CY; Kho, KW; Olivo, M; Saw, CL; Sia Heng, PW; Soo, KC; Wohland, T, 2007) |
| "Photosensitization of HEC1-B cells with a low concentration of hypericin and doses of light below 10 J/cm(2) caused cell death (apoptosis occurred mainly at doses between 2 and 5 J/cm(2), whereas necrosis prevailed above 6 J/cm(2))." | 3.71 | Molecular aspects of photodynamic therapy: low energy pre-sensitization of hypericin-loaded human endometrial carcinoma cells enhances photo-tolerance, alters gene expression and affects the cell cycle. ( Coppola, E; Palumbo, G; Quarto, M; Varriale, L; Veneziani, BM, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziegler, V | 1 |
| Kiesslich, T | 1 |
| Krammer, B | 1 |
| Plaetzer, K | 1 |
| Zhu, M | 1 |
| Lin, XA | 1 |
| Zha, XM | 1 |
| Zhou, WB | 1 |
| Xia, TS | 1 |
| Wang, S | 1 |
| Li, Y | 1 |
| Zhang, J | 1 |
| Wang, B | 1 |
| Shen, Y | 1 |
| Ouahab, A | 1 |
| Roelants, M | 1 |
| Van Cleynenbreugel, B | 1 |
| Lerut, E | 1 |
| Van Poppel, H | 1 |
| de Witte, PA | 1 |
| Siboni, G | 1 |
| Amit-Patito, I | 1 |
| Weizman, E | 1 |
| Waintraub-Porat, M | 1 |
| Weitman, H | 1 |
| Ehrenberg, B | 1 |
| Malik, Z | 1 |
| Du, HY | 1 |
| Olivo, M | 2 |
| Chen, YJ | 1 |
| Yip, G | 1 |
| Tan, PH | 1 |
| Matsumoto, K | 1 |
| Tsujimoto, M | 1 |
| Bay, BH | 1 |
| Saw, CL | 1 |
| Wohland, T | 1 |
| Fu, CY | 1 |
| Kho, KW | 1 |
| Soo, KC | 1 |
| Sia Heng, PW | 1 |
| Varriale, L | 1 |
| Coppola, E | 1 |
| Quarto, M | 1 |
| Veneziani, BM | 1 |
| Palumbo, G | 1 |
8 other studies available for hypericin and Carcinoma
| Article | Year |
|---|---|
Photosensitizer adhered to cell culture microplates induces phototoxicity in carcinoma cells.
Topics: Anthracenes; Carcinoma; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Membrane; Cul | 2013 |
Evaluation of the therapeutic efficacy of sequential therapy involving percutaneous microwave ablation in combination with 131I-hypericin using the VX2 rabbit breast solid tumor model.
Topics: Ablation Techniques; Animals; Anthracenes; Antineoplastic Agents; Carcinoma; Drug Evaluation, Precli | 2015 |
Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
Topics: Anthracenes; Carcinoma; Cell Line, Tumor; Humans; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha | 2016 |
Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids.
Topics: Anthracenes; Carcinoma; Cells, Cultured; Humans; Perylene; Photochemotherapy; Photosensitizing Agent | 2011 |
Specificity of photosensitizer accumulation in undifferentiated versus differentiated colon carcinoma cells.
Topics: Animals; Anthracenes; Butyrates; Carcinoma; Cell Cycle; Cell Differentiation; Colonic Neoplasms; Mic | 2003 |
Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo.
Topics: Animals; Anthracenes; Antineoplastic Agents; Carcinoma; Humans; Male; Mice; Mice, Inbred BALB C; Nas | 2005 |
Effects of N-methyl pyrrolidone on the uptake of hypericin in human bladder carcinoma and co-staining with DAPI investigated by confocal microscopy.
Topics: Anthracenes; Antineoplastic Agents; Biological Availability; Carcinoma; Diagnostic Imaging; Dose-Res | 2007 |
Molecular aspects of photodynamic therapy: low energy pre-sensitization of hypericin-loaded human endometrial carcinoma cells enhances photo-tolerance, alters gene expression and affects the cell cycle.
Topics: Anthracenes; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Biological Transport; Carcinoma; | 2002 |